SLNCF
Price:
$2.21
Market Cap:
$316.94M
Silence Therapeutics plc, a biotechnology firm headquartered in London, United Kingdom, is dedicated to the discovery and advancement of pioneering ribonucleic acid (RNA) therapeutics. Its research and development efforts span key areas such as blood disorders, cardiovascular health, and other uncommon and metabolic ailments. Central to the company's approach is its proprietary mRNAi GalNAc Oligonucleotide Discovery platform, meticulously crafted to precisely target specific disease-causing genes, predominantly within the liver. This mechanism involves creating short interfering RNA (siRNA) molecules that activate the body's intrinsic RNA interference pathway, effectively breaking down messe...[Read more]
Industry
Biotechnology
IPO Date
2012-09-25
Stock Exchange
OTC
Ticker
SLNCF
According to Silence Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -4.09. This represents a change of 38.05% compared to the average of -2.96 of the last 4 quarters.
The mean historical PE Ratio of Silence Therapeutics plc over the last ten years is -32.89. The current -4.09 PE Ratio has changed 1.14% with respect to the historical average. Over the past ten years (40 quarters), SLNCF's PE Ratio was at its highest in in the September 2017 quarter at 43.57. The PE Ratio was at its lowest in in the December 2016 quarter at -49.57.
Average
-32.89
Median
-13.38
Minimum
-207.98
Maximum
-1.87
Discovering the peaks and valleys of Silence Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 377.61%
Maximum Annual PE Ratio = -1.87
Minimum Annual Increase = -90.64%
Minimum Annual PE Ratio = -207.98
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.24 | 73.24% |
| 2024 | -1.87 | -52.07% |
| 2023 | -3.90 | 18.37% |
| 2022 | -3.30 | -75.17% |
| 2021 | -13.28 | -1.52% |
| 2020 | -13.49 | -28.29% |
| 2019 | -18.80 | -3.36% |
| 2018 | -19.46 | -90.64% |
| 2017 | -207.98 | 377.61% |
| 2016 | -43.55 | 2.46% |
The current PE Ratio of Silence Therapeutics plc (SLNCF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.00
5-year avg
-5.12
10-year avg
-32.89
Silence Therapeutics plc’s PE Ratio is greater than Hansa Biopharma AB (publ) (-4.74), less than Transgene S.A. (-3.20), less than Santhera Pharmaceuticals Holding AG (-4.09), greater than hVIVO plc (-9.02), greater than Genfit S.A. (-5.50), less than Mayne Pharma Group Limited (-2.28), greater than Oryzon Genomics S.A. (-111.13), less than JW (Cayman) Therapeutics Co. Ltd (-1.05), less than Brii Biosciences Limited (-2.77), greater than Cellectis S.A. (-4.67),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.74 | $245.80M | |
| -3.20 | $122.57M | |
| -4.09 | $344.83M | |
| -9.02 | $75.45M | |
| -5.50 | $499.80M | |
| -2.28 | $134.06M | |
| -111.13 | $282.54M | |
| -1.05 | $98.91M | |
| -2.77 | $107.82M | |
| -4.67 | $251.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silence Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Silence Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Silence Therapeutics plc's PE Ratio?
How is the PE Ratio calculated for Silence Therapeutics plc (SLNCF)?
What is the highest PE Ratio for Silence Therapeutics plc (SLNCF)?
What is the 3-year average PE Ratio for Silence Therapeutics plc (SLNCF)?
What is the 5-year average PE Ratio for Silence Therapeutics plc (SLNCF)?
How does the current PE Ratio for Silence Therapeutics plc (SLNCF) compare to its historical average?